Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis
Stopped early · Phase 3 · Has a placebo group
Conditions studied: Nonalcoholic Steatohepatitis
In brief
The primary objective of this study is to evaluate whether selonsertib (SEL; GS-4997) can cause fibrosis regression and reduce progression to cirrhosis and associated complications in adults with NASH and bridging (F3) fibrosis.
Key facts
- Study ID
- NCT03053050
- Run by
- Gilead Sciences
- People needed
- 808
- Starts
- 2017-02-13
- Expected to finish
- 2019-06-19
- Last updated by the study team
- 2020-06-29
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Banner University Medical Center-Phoenix — Phoenix, Arizona, United States
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona, United States
- Mayo Clinic — Phoenix, Arizona, United States
- University of Arizona — Tucson, Arizona, United States
- Baptist Medical Center — Little Rock, Arkansas, United States
- Arkansas Gastroenterology — North Little Rock, Arkansas, United States
- eStudySite — Chula Vista, California, United States
- Southern California Liver Centers — Coronado, California, United States
- United Gastroenterologists — Costa Mesa, California, United States
- TriWest Research Associates, LLC — El Cajon, California, United States
- Fresno Clinical Research Center — Fresno, California, United States
- University of California San Diego (UCSD) — La Jolla, California, United States
- Ruane Clinical Research Group — Los Angeles, California, United States
- Cedars Sinai Medical Center — Los Angeles, California, United States
- VA Greater Los Angeles Healthcare System — Los Angeles, California, United States
- eStudySite — Oceanside, California, United States
- California Liver Institute — Pasadena, California, United States
- Inland Empire Liver Foundation — Rialto, California, United States
- University of California, Davis Medical Center — Sacramento, California, United States
- Medical Associates Research Group — San Diego, California, United States
- Kaiser Permanente — San Diego, California, United States
- California Pacific Medical Center - Sutter Pacific Medical Foundation San Francisco Center for Liver Disease Dept. of Transplant — San Francisco, California, United States
- Mission Gastroenterology and Hepatology — San Francisco, California, United States
- University of California San Francisco (UCSF) — San Francisco, California, United States
- Institute of Liver Health — Chandler, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.